Session Detail


Session Title: Late-Breaking Research: Epidemiology
Session Type: Late-Breaking Poster Session
Session Start/End Time: Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Location: Hall A-E, Poster Section 47
Presentations:
LB-12: Plasma 25-hydroxyvitamin D levels are associated with aggressive prostate cancer among African Americans in the North Carolina-Louisiana Prostate Cancer Project (PCaP)
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Anna Woloszynska-Read, Lenore Arab, John Adams, Jeannette T. Bensen, Elizabeth TH Fontham, James L. Mohler, Joseph Su, Fred Tabung, Hongmei Zhang, Donald L. Trump, Candace S. Johnson, Susan E. Steck. Roswell Park Cancer Institute, Buffalo, NY, University of California, Los Angeles, CA, University of North Carolina, Chapel Hill, NC, Louisiana State University, New Orleans, LA, National Cancer Institute, Bethesda, MD, University of South Carolina, Columbia, SC
LB-13: Early life exposures and breast cancer (BC) risk among African American (AA) and European American (EA) women
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Mark L. Glasgow, Jo Freudenheim, Gary Zirpoli, Elisa Bandera, Christine Ambrosone. The State University of New York at Buffalo, Buffalo, NY, Roswell Park Cancer Institute, Buffalo, NY, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ
LB-14: High-risk cervical human papillomavirus infections among human immunodeficiency virus-positive women in the Bahamas
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Elizabeth Blackman, Dionne N. Dames, Raleigh Butler, Emanuela Taioli, Stacy Eckstein, Karthik Devarajan, Andrea Griffith-Bowe, Perry Gomez, Camille Ragin. Fox Chase Cancer Center, Philadelphia, PA, Princess Margaret Hospital, Nassau, Bahamas, Hofstra North Shore-LIJ School of Medicine, Philadelphia, PA, University of Pittsburgh, Pittsburgh, PA
LB-15: Frequency of aspirin use and prostate cancer mortality among prostate cancer cases in the control arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Sarah E. Daugherty, Ruth Pfeiffer, Armen Ghazarian, Grant Izmirlian, Phil Prorok, Katherine McGlynn. National Cancer Inst., Rockville, MD
LB-16: Breast cancer risk in association with occupational exposure to organic solvents
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Christine Ekenga, Christine G. Parks, Aimee A. D'Aloisio, Lisa A. DeRoo, Dale P. Sandler. NIH / National Institute of Environmental Health Sciences, Research Triangle Park, NC
LB-17: Missing the benefit of metformin in AML: A problem of contrast
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Zachary A. P. Wintrob, Huan-Ching Chuang, Dustyn S. Miller, Jonathan L. Rabey, Thang Q. Bui, Michelle E. Amsler, Laurie-Ann Ford, Meir Wetzler, Alice C. Ceacareanu. SUNY at Buffalo, Buffalo, NY, Roswell Park Cancer Institute, Buffalo, NY
LB-18: Statins use prevents ovarian cancer recurrence in women with diabetes mellitus
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Michelle E. Amsler, Kristina A. Chmiel, Olesya Yaremko, Clare Carroll, Jingjing Yin, Terry Mashtare, Anthony Miliotto, Rachel Brightwell, Kunle Odunsi, Alice C. Ceacareanu. State University of New York, Buffalo, NY, Roswell Park Cancer Institute, Buffalo, NY
LB-19: Plasma levels of pre-diagnostic sex hormones and mortality among patients with colorectal cancer - Results from four cohort studies
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Xuehong Zhang, Edward L. Giovannucci, Andrew T. Chan, Kana Wu, Charles S. Fuchs, I-Min Lee, Julie E. Buring, J. Michael Gaziano, Howard D. Sesso, Jennifer H. Lin. Harvard Medical School and Brigham and Women's Hospital, Boston, MA, Brigham and Women's Hospital, Boston, MA
LB-20: Serum antioxidant levels and survival time in advanced non-small cell lung cancer patients
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Kosin Wirasorn, Pranithi Hongprabhas, Veeradej Pisprasert, Kulthida Klarod, Patcharee Boonsiri. Khonkaen University, Khonkaen, Thailand, University of Alabama at Birmingham, Birmingham, AL, Burapa University, Chonburi, Thailand
LB-21: Growth factor genes and change in mammographic density after quitting estrogen and progestin hormone therapy in the California Teachers Study
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Eunjung Lee, Fred Schumacher, Anna H. Wu, Leslie Bernstein, Giske Ursin. USC/Norris Comprehensive Cancer Ctr., Los Angeles, CA, City of Hope, Duarte, CA, Cancer Registry of Norway, Oslo, Norway
LB-22: P53 genetic polymorphisms, interactions with lifestyle factors and lung cancer risk in a Chinese population
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Yanli Li, Shen-Chih Chang, Rungui Niu, Li Liu, Christina R. Crabtree-Ide, Baoxing Zhao, Jianping Shi, Xiaoyou Han, Jiawei Li, Jia Su, Lin Cai, Shunzhang Yu, Zuo-Feng Zhabg, Lina Mu. SUNY at Buffalo, Buffalo, NY, University of California, Los Angeles (UCLA), Los Angeles, CA, Shanxi Tumor Hospital, Taiyuan, China, Taiyuan City Center for Disease Control and Prevention, Taiyuan, China, Fudan University, Shanghai, China, Fujian Medical University, Fuzhou, China
LB-23: Meta-analysis of genome-wide association studies identifies multiple loci associated with chronic lymphocytic leukemia
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Sonja I. Berndt, Christine F. Skibola, Vijai Joseph, Nicola J. Camp, Alexandra Nieters, Zhaoming Wang, Wendy Cozen, Alain Monnereau, Rachel S. Kelly, Silvia De Sanjose, Martha S. Linet, Elio Riboli, Paolo Vineis, Henrik Hjalgrim, James R. Cerhan, Stephen J. Chanock, Nathaniel Rothman, Susan L. Slager. National Cancer Institute, Bethesda, MD, University of Alabama, Birmingham, AL, Memorial Sloan-Kettering Cancer Center, New York, NY, University of Utah School of Medicine, Salt Lake City, UT, University Medical Center Freiburg, Freiburg, Germany, University of Southern California, Los Angeles, CA, Institut National de la Sante et de la Recherche Medicale, Villejuif Cedex, France, Imperial College London, London, United Kingdom, Institut Catala d'Oncologi, Barcelona, Spain, Statens Serum Institut, Copenhagen, Denmark, Mayo Clinic, Rochester, MN
LB-24: Association between drug metabolizing and DNA-repair enzyme polymorphisms and overall survival of colorectal cancer patients treated with 5-FU based adjuvant chemotherapy in Taiwan
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Ching-Yu Lai, Fung-Chang Sung, Ling-Ling Hsieh, Reiping Tang, Fang-Yang Wu, Hung-Yi Chiou, Chih-Ching Yeh. China Medical Univ., Taichung City, Taiwan, Chang Gung University, Taoyuan, Taiwan, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Taipei Medical Univ., Taipei City, Taiwan
LB-25: Exploration of genome-wide circulating microRNA in hepatocellular carcinoma (HCC) - dysregulation of miR-483-5p and miR-150 as diagnostic marker
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Jing Shen, Antai Wang, Qiao Wang, Irina Gurvich, Abby B. Siegel, Helen Remotti, Regina M. Santella. Columbia University Medical Center, New York, NY
LB-26: Biomarker changes in the endometrium of morbidly obese women undergoing bariatric surgery: Implications for endometrial cancer risk reduction?
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Faina Y. Linkov, Robert Edwards, Marina L. Komaroff, Esther Elishaev, Nika Gloyeske, Peter Argenta. University of Pittsburgh, Pittsburgh, PA, SUNY Downstate, Brookline, MA, University of Minnesota, Minneapolis, MN
LB-27: Metabolomic profiling identifies bilirubin as a novel serum marker for lung cancer
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Fanmao Zhang, Chi Pang Wen, Dong Liang, Heath Skinner, Jian Gu, Wong-Ho Chow, Yuanqing Ye, Michelle A.T. Hildebrandt, Xia Pu, Maosheng Huang, Min Kuang Tsai, Chwen Keng Tsao, Xifeng Wu. UT MD Anderson Cancer Ctr., Houston, TX, National Health Research Institutes, Zhunan, Taiwan, Texas Southern University, Houston, TX, MJ Health Management Institution, Taipei, Taiwan
LB-28: The IGF/insulin signaling axis TMPRSS2:ERG and prostate cancer survival
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Thomas U. Ahearn, Andreas Pettersson, Edward C. Stack, Jing Ma, Travis Gerke, Allison Meisner, Michael N. Pollak, Stephen Finn, Meir J. Stampfer, Massimo Loda, Edward L. Giovannucci, Lorelei A. Mucci. Harvard School of Public Health, Boston, MA, Dana-Farber Cancer Institute, Boston, MA, McGill University, Montreal, QC, Canada
LB-29: Hormonal risk factors and breast cancer prognosis and survival by PAM50 molecular subtype
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Marilyn L. Kwan, Carol Sweeney, Laurel A. Habel, Erin Weltzien, Adrienne Castillo, Carole Davis, Rachel E. Factor, Candyce H. Kroenke, Kaylynn Shakespear, Charles P. Quesenberry Jr., Inge J. Stijleman, Philip S. Bernard, Lawrence H. Kushi, Bette J. Caan. Kaiser Permanente Northern California, Oakland, CA, University of Utah, Salt Lake City, UT
LB-30: Metabolomic profile of response to β-carotene supplementation reveals potential for pharmacologic interactions with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Alison M. Mondul, Steven C. Moore, Joshua N. Sampson, Stephanie J. Weinstein, Edward D. Karoly, Jarmo Virtamo, Demetrius Albanes. NCI-DCEG, Rockville, MD, Metabolon, Inc., Durham, NC, National Institute for Health and Welfare, Helsinki, Finland
LB-31: Maternal supplementation with folic acid and other vitamins before and during pregnancy and risk of leukemia in the offspring: A childhood leukemia international consortium (CLIC) study
Sunday, Apr 07, 2013, 1:00 PM - 5:00 PM
Catherine Metayer, Elizabeth Milne, John D. Dockerty, Jacqueline Clavel, Maria S. Pombo-de-Oliveira, Catharina Wesseling, Logan G. Spector, Joachim Schüz, Eleni Petridou, Sameera Ezzat, Bruce K. Armstrong, Jérémie Rudant, Sergio Koifman, Peter Kaatsch, Maria Moschovi, Wafaa Rashed, Steve Selvin, Kathryn McCauley, Alice Y. Kang, Rayjean J. Hung, Patricia A. Buffler, Claire Infante-Rivard. University of California, Berkeley, CA, University of Western Australia, West Perth, Australia, University of Otago, Dunedin, New Zealand, Université Paris-Sud, Villejuif, France, Instituto Nacional de Cancer, Rio de Janeiro, Brazil, Central American Institute for Studies on Toxic Substances, Universidad Nacional, Heredia, Costa Rica, University of Minnesota, Minneapolis, MN, International Agency for Research on Cancer, Lyon, France, University of Athens, Medical School, Athens, Greece, Menoufiya University and Children's Cancer Hospital 57357, Cairo, Egypt, University of Sydney, Sydney, Australia, National School of Public Health, Rio de Janeiro, Brazil, University Mainz, Mainz, Germany, Samuel Lunenfeld Research Institute of Mount Sinai Hospital, Toronto, ON, Canada, McGill University, Montréal, QC, Canada